Skip to content
naulon
Not checkedNot checked for notices yet.

Empowering women to take control over cervical screening

The Lancet Regional Health. Western Pacific · 2021

doi:10.1016/j.lanwpc.2021.100339 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

A study published in The Lancet on Nov 2, 2021, shows that the introduction of the human papillomavirus (HPV) immunisation programme in England, UK has led to an 87% relative reduction in cervical cancer cases in women who were vaccinated when they were aged 12–13 years. Cervical cancer is the fourth most common cancer in women and most cases are caused by HPV infection. WHO estimated that 604 000 new cases and 342 000 deaths due to cervical cancer occurred globally in 2020. In the Western Pacific region, approximately 193 000 women were diagnosed with cervical cancer and 74 900 women died from the disease in the same year.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.